[Drug metaphylaxis of urolithiasis].
D002129:Calcium Oxalate / Q000032:analysis; D003545:Cysteine / Q000032:analysis; D006801:Humans; D008274:Magnesium / Q000032:analysis; D017616:Magnesium Compounds; D010710:Phosphates / Q000032:analysis; D000644:Quaternary Ammonium Compounds / Q000032:analysis; D000069877:Struvite; D014527:Uric Acid / Q000032:analysis; D014545:Urinary Calculi / Q000032:analysis / Q000517:prevention & control*
D017616:Magnesium Compounds; D010710:Phosphates; D000644:Quaternary Ammonium Compounds; D002129:Calcium Oxalate; D014527:Uric Acid; D000069877:Struvite; D008274:Magnesium; D003545:Cysteine
Medikamentöse Metaphylaxe der Urolithiasis.